Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera<sup>®</sup> Protocol: A Score Proposal

Hernán Pinto; Rafael Gálvez; José Casanova

doi:doi:10.11648/j.ijcda.20180401.12

| Peer-Reviewed

Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera^® Protocol: A Score Proposal

Hernán Pinto, Rafael Gálvez, José Casanova

Published in International Journal of Clinical and Developmental Anatomy (Volume 4, Issue 1)

Received: 13 November 2017 Accepted: 29 November 2017 Published: 26 February 2018

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

There is no actual treatment capable of creating hair follicles de novo, since a hair follicle is not a single tissue but a tiny, full anatomical structure. The Regenera^® method is based on the regeneration and recovery of severely non-functional but still-alive hair follicles. For 1.5 years, clinical assessment has been the sole pillar of any outcome prospection issued. Wrong prospections could be affecting about 10% of patients expecting good results. Scalp dermoscopy was then included in routine diagnosis tests of every patient willing to be treated with the Regenera^® protocol. When analyzing the data of the dermoscopy of patients with a poor prospection, it was clear that the expectancies related to the treatment´s results were overestimated.

Published in	International Journal of Clinical and Developmental Anatomy (Volume 4, Issue 1)
DOI	10.11648/j.ijcda.20180401.12
Page(s)	15-18
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2018. Published by Science Publishing Group

Keywords

Regenera, Androgenetic Alopecia, Score, Hair Loss

References

[1]	Purpura V, Bondioli E, Graziano A, Trovato L, Melandri D, Ghetti M, et al. Tissue Characterization after a New Disaggregation Method for Skin Micro-Grafts Generation. J Vis Exp 2016 Mar 4; (109).
[2]	Niezgoda A, Niezgoda P, Nowowiejska L, Białecka A, Męcińska-Jundziłł K, Adamska U, Czajkowski R. Properties of skin stem cells and their potential clinical applications in modern dermatology. Eur J Dermatol 2017 Mar 11. doi: 10.1684/ejd.2017.2988. [Epub ahead of print].
[3]	Ibrahim ZA, Elmaadawi IH, Mohamed BM, Abdou SM, El Attar YA, Youssef A, Shamloula MM, Taha A, Gabr Metwally H, El Afandy MM, Salem ML. Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia. J Dermatolog Treat 2016 Aug 24: 1-30.
[4]	Svolacchia, Fabiano, Francesco De Francesco, Letizia Trovato, Antonio Graziano, and Giuseppe A. Ferraro. An Innovative Regenerative Treatment of Scars with Dermal Micrografts. Journal of Cosmetic Dermatology 2016 Sep; 15 (3): 245-53.
[5]	Giaccone M, Brunetti M, Camandona M, Trovato L, Graziano A. A New Medical Device, Based on Rigenera Protocol, in the Management of Complex Wounds. J Stem Cells Res, Rev & Rep 2014; 1 (3): 1013.
[6]	Jha AK, Udayan UK, Roy PK, Amar AKJ, Chaudhary RKP. Dermoscopy of alopecia areata-a retrospective analysis. Dermatol Pract Concept 2017 Apr 30; 7 (2): 53-57.
[7]	Guttikonda AS, Aruna C, Ramamurthy DV, Sridevi K, Alagappan SK. Evaluation of Clinical Significance of Dermoscopy in Alopecia Areata. Indian J Dermatol 2016 Nov-Dec; 61 (6): 628-633.
[8]	Moreno-Arrones OM, Saceda-Corralo D, Fonda-Pascual P, Rodrigues-Barata AR, Buendía-Castaño D, Alegre-Sánchez A, Pindado-Ortega C, Molins M, Perosanz D, Segurado-Miravalles G, Jaén P, Vañó-Galván S. Frontal fibrosing alopecia: clinical and prognostic classification. J Eur Acad Dermatol Venereol 2017 Apr 20. doi: 10.1111/jdv.14287. [Epub ahead of print].
[9]	Younger J, Gandhi V, Hubbard E, Mackey S. Development of the Stanford Expectations of Treatment Scale (SETS): a tool for measuring patient outcome expectancy in clinical trials. Clin Trials 2012 Dec; 9 (6): 767-76.
[10]	Guarrera M, Cardo P, Arrigo P, Rebora A. Reliability of hamilton-norwood classification. Int J Trichology 2009 Jul; 1 (2): 120-2.
[11]	Hong H, Ji JH, Lee Y, Kang H, Choi GS, Lee WS. Reliability of the pattern hair loss classifications: a comparison of the basic and specific and Norwood-Hamilton classifications. J Dermatol 2013 Feb; 40 (2): 102-6.

Cite This Article

Plain Text BibTeX RIS

APA Style

Hernán Pinto, Rafael Gálvez, José Casanova. (2018). Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal. International Journal of Clinical and Developmental Anatomy, 4(1), 15-18. https://doi.org/10.11648/j.ijcda.20180401.12

Copy | Download

ACS Style

Hernán Pinto; Rafael Gálvez; José Casanova. Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal. Int. J. Clin. Dev. Anat. 2018, 4(1), 15-18. doi: 10.11648/j.ijcda.20180401.12

Copy | Download

AMA Style

Hernán Pinto, Rafael Gálvez, José Casanova. Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal. Int J Clin Dev Anat. 2018;4(1):15-18. doi: 10.11648/j.ijcda.20180401.12

Copy | Download

@article{10.11648/j.ijcda.20180401.12,
  author = {Hernán Pinto and Rafael Gálvez and José Casanova},
  title = {Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal},
  journal = {International Journal of Clinical and Developmental Anatomy},
  volume = {4},
  number = {1},
  pages = {15-18},
  doi = {10.11648/j.ijcda.20180401.12},
  url = {https://doi.org/10.11648/j.ijcda.20180401.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcda.20180401.12},
  abstract = {There is no actual treatment capable of creating hair follicles de novo, since a hair follicle is not a single tissue but a tiny, full anatomical structure. The Regenera® method is based on the regeneration and recovery of severely non-functional but still-alive hair follicles. For 1.5 years, clinical assessment has been the sole pillar of any outcome prospection issued. Wrong prospections could be affecting about 10% of patients expecting good results. Scalp dermoscopy was then included in routine diagnosis tests of every patient willing to be treated with the Regenera® protocol. When analyzing the data of the dermoscopy of patients with a poor prospection, it was clear that the expectancies related to the treatment´s results were overestimated.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal
AU  - Hernán Pinto
AU  - Rafael Gálvez
AU  - José Casanova
Y1  - 2018/02/26
PY  - 2018
N1  - https://doi.org/10.11648/j.ijcda.20180401.12
DO  - 10.11648/j.ijcda.20180401.12
T2  - International Journal of Clinical and Developmental Anatomy
JF  - International Journal of Clinical and Developmental Anatomy
JO  - International Journal of Clinical and Developmental Anatomy
SP  - 15
EP  - 18
PB  - Science Publishing Group
SN  - 2469-8008
UR  - https://doi.org/10.11648/j.ijcda.20180401.12
AB  - There is no actual treatment capable of creating hair follicles de novo, since a hair follicle is not a single tissue but a tiny, full anatomical structure. The Regenera® method is based on the regeneration and recovery of severely non-functional but still-alive hair follicles. For 1.5 years, clinical assessment has been the sole pillar of any outcome prospection issued. Wrong prospections could be affecting about 10% of patients expecting good results. Scalp dermoscopy was then included in routine diagnosis tests of every patient willing to be treated with the Regenera® protocol. When analyzing the data of the dermoscopy of patients with a poor prospection, it was clear that the expectancies related to the treatment´s results were overestimated.
VL  - 4
IS  - 1
ER  -

Copy | Download

Author Information

Hernán Pinto

Department of Medical, Biomedical Research Institute, Barcelona, Spain
Rafael Gálvez

Giroclinic, Girona, Spain
José Casanova

Giroclinic, Girona, Spain

Download PDF

Submit an Article

Sections

Plain Text BibTeX RIS

APA Style

Hernán Pinto, Rafael Gálvez, José Casanova. (2018). Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal. International Journal of Clinical and Developmental Anatomy, 4(1), 15-18. https://doi.org/10.11648/j.ijcda.20180401.12

Copy | Download

ACS Style

Hernán Pinto; Rafael Gálvez; José Casanova. Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal. Int. J. Clin. Dev. Anat. 2018, 4(1), 15-18. doi: 10.11648/j.ijcda.20180401.12

Copy | Download

AMA Style

Hernán Pinto, Rafael Gálvez, José Casanova. Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal. Int J Clin Dev Anat. 2018;4(1):15-18. doi: 10.11648/j.ijcda.20180401.12

Copy | Download

@article{10.11648/j.ijcda.20180401.12,
  author = {Hernán Pinto and Rafael Gálvez and José Casanova},
  title = {Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal},
  journal = {International Journal of Clinical and Developmental Anatomy},
  volume = {4},
  number = {1},
  pages = {15-18},
  doi = {10.11648/j.ijcda.20180401.12},
  url = {https://doi.org/10.11648/j.ijcda.20180401.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcda.20180401.12},
  abstract = {There is no actual treatment capable of creating hair follicles de novo, since a hair follicle is not a single tissue but a tiny, full anatomical structure. The Regenera® method is based on the regeneration and recovery of severely non-functional but still-alive hair follicles. For 1.5 years, clinical assessment has been the sole pillar of any outcome prospection issued. Wrong prospections could be affecting about 10% of patients expecting good results. Scalp dermoscopy was then included in routine diagnosis tests of every patient willing to be treated with the Regenera® protocol. When analyzing the data of the dermoscopy of patients with a poor prospection, it was clear that the expectancies related to the treatment´s results were overestimated.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Dermoscopy Is the Crucial Step for Proper Outcome Prospection When Treating Androgenetic Alopecia with the Regenera® Protocol: A Score Proposal
AU  - Hernán Pinto
AU  - Rafael Gálvez
AU  - José Casanova
Y1  - 2018/02/26
PY  - 2018
N1  - https://doi.org/10.11648/j.ijcda.20180401.12
DO  - 10.11648/j.ijcda.20180401.12
T2  - International Journal of Clinical and Developmental Anatomy
JF  - International Journal of Clinical and Developmental Anatomy
JO  - International Journal of Clinical and Developmental Anatomy
SP  - 15
EP  - 18
PB  - Science Publishing Group
SN  - 2469-8008
UR  - https://doi.org/10.11648/j.ijcda.20180401.12
AB  - There is no actual treatment capable of creating hair follicles de novo, since a hair follicle is not a single tissue but a tiny, full anatomical structure. The Regenera® method is based on the regeneration and recovery of severely non-functional but still-alive hair follicles. For 1.5 years, clinical assessment has been the sole pillar of any outcome prospection issued. Wrong prospections could be affecting about 10% of patients expecting good results. Scalp dermoscopy was then included in routine diagnosis tests of every patient willing to be treated with the Regenera® protocol. When analyzing the data of the dermoscopy of patients with a poor prospection, it was clear that the expectancies related to the treatment´s results were overestimated.
VL  - 4
IS  - 1
ER  -

Copy | Download